AKEBIA THERAPEUTICS, INC. (AKBA) Revenue 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$236.2MFY2025 · since FY2016: $1.5M → $236.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $236.2M | +47.5% |
| FY2024 | $160.2M | -17.7% |
| FY2023 | $194.6M | -33.5% |
| FY2022 | $292.5M | +38.2% |
| FY2021 | $211.7M | -28.2% |
| FY2020 | $294.6M | -12.0% |
| FY2019 | $335.0M | +61.3% |
| FY2018 | $207.7M | +14.6% |
| FY2017 | $181.2M | +11706.3% |
| FY2016 | $1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice